# The emerging role of ubiquitin-proteasome system dysfunction in the pathogenesis of perioperative neurocognitive disorders: a narrative review

**Authors:** Minghua Ma, Jing Yang, Yuan Yang, Lin Li

PMC · DOI: 10.3389/fnbeh.2026.1762088 · Frontiers in Behavioral Neuroscience · 2026-02-12

## TL;DR

This review explores how dysfunction in the ubiquitin-proteasome system contributes to neurocognitive issues after surgery, especially in older adults.

## Contribution

The paper highlights the UPS as a novel target for understanding and treating perioperative neurocognitive disorders.

## Key findings

- UPS dysfunction is linked to the development of perioperative neurocognitive disorders.
- Potential biomarkers and treatment strategies targeting the UPS are discussed.
- The review offers a theoretical foundation for new interventions in PND.

## Abstract

Perioperative neurocognitive disorder (PND) is a prevalent and serious complication affecting the central nervous system following surgery, particularly among elderly patients. PND has a significant impact on patient prognosis and places a substantial burden on both individuals and the healthcare system. Despite its importance, the complex pathological mechanisms underlying PND remain inadequately understood, and there are currently no effective prevention or treatment strategies available. One critical factor contributing to PND is the imbalance in protein homeostasis, with the ubiquitin-proteasome system (UPS), recognized as the primary mechanism for protein quality control within cells. This review systematically discusses the crucial role of UPS dysfunction in the development of PND. Additionally, it analyzes potential biomarkers for diagnosing PND and explores treatment strategies targeting the UPS. This provides a new perspective for a deeper understanding of the molecular mechanisms involved in PND and lays a theoretical foundation for the development of new intervention methods.

## Full-text entities

- **Genes:** Marchf5 (membrane associated ring-CH-type finger 5) [NCBI Gene 69104] {aka 1810015H18Rik, 2310008I22Rik, 2700055A20Rik, 5730499H23Rik, E130202O05Rik, MARCH-V}, Fbxl19 (F-box and leucine-rich repeat protein 19) [NCBI Gene 233902] {aka 6030430O11, Fbl19}, Wdr48 (WD repeat domain 48) [NCBI Gene 67561] {aka 8430408H12Rik, Uaf1, mKIAA1449}, St13 (suppression of tumorigenicity 13) [NCBI Gene 70356] {aka 1110007I03Rik, 3110002K08Rik, HIP, HOP, HSPABP, HSPABP1}, Nrf1 (nuclear respiratory factor 1) [NCBI Gene 18181] {aka D6Ertd415e}, Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}, Ido1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 15930] {aka Ido, Indo}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, Pde5a (phosphodiesterase 5A, cGMP-specific) [NCBI Gene 242202] {aka Cgbpde, Cn5n, PDE5a2, Pde5, Pde5a1}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Usp47 (ubiquitin specific peptidase 47) [NCBI Gene 74996] {aka 4930502N04Rik, A630020C16Rik}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Snap25 (synaptosomal-associated protein 25) [NCBI Gene 20614] {aka Bdr, GENA70, SNAP-25, SUP, sp}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) [NCBI Gene 20525] {aka GT1, Glut-1, Glut1, M100200, Rgsc200}, Tnfaip1 (tumor necrosis factor, alpha-induced protein 1 (endothelial)) [NCBI Gene 21927] {aka Bacurd2, Edp-1, Edp1, Tnfip1}, HMBS (hydroxymethylbilane synthase) [NCBI Gene 3145] {aka ENCEP, LENCEP, PBG-D, PBGD, PORC, UPS}, Pgp (phosphoglycolate phosphatase) [NCBI Gene 67078] {aka 1700012G19Rik, AUM, G3PP}, Hace1 (HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1) [NCBI Gene 209462] {aka 1700042J16Rik, A730034A22Rik}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Rnf216 (ring finger protein 216) [NCBI Gene 108086] {aka 2810055G22Rik, F830018F18Rik, TRIAD3, UIP83, Ubce7ip1}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Optn (optineurin) [NCBI Gene 71648] {aka 4930441O07Rik, FIP2, HYPL, NRP}, Aqp4 (aquaporin 4) [NCBI Gene 11829] {aka WCH4}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Rnf123 (ring finger protein 123) [NCBI Gene 84585] {aka Kpc1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Mib2 (mindbomb E3 ubiquitin protein ligase 2) [NCBI Gene 76580] {aka 2210008I11Rik, Zzank1, skd}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Usp7 (ubiquitin specific peptidase 7) [NCBI Gene 252870] {aka 2210010O09Rik, Hausp}, Usp14 (ubiquitin specific peptidase 14) [NCBI Gene 59025] {aka 2610005K12Rik, 2610037B11Rik, ax, nmf375}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Hmbs (hydroxymethylbilane synthase) [NCBI Gene 15288] {aka PBGD, Ups, Uros1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Pten (phosphatase and tensin homolog) [NCBI Gene 19211] {aka 2310035O07Rik, A130070J02Rik, B430203M17Rik, MMAC1, PTENbeta, TEP1}, Tomm40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 53333] {aka Mom35, Tom40}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}
- **Diseases:** dementia (MESH:D003704), Glymphatic dysfunction (MESH:D006331), neuronal damage (MESH:D009410), memory impairment (MESH:D008569), infectious diseases (MESH:D003141), cognitive decline (MESH:D003072), neurological impairment (MESH:D009422), colorectal cancer (MESH:D015179), nerve damage (MESH:D000080902), mitochondrial defects (MESH:C565376), neuro-pathological damage (MESH:C536203), toxicity (MESH:D064420), postoperative complication (MESH:D011183), PND (MESH:D019965), learning deficits (MESH:D007859), POD (MESH:D000071257), synaptic damage (MESH:D012183), neuronal dysfunction (MESH:D009461), energy metabolism (MESH:D008659), PD (MESH:D010300), Mitochondrial damage (MESH:D028361), inattention (MESH:D001308), POCD (MESH:D000079690), trauma (MESH:D014947), neurodegenerative disease (MESH:D019636), UPS dysfunction (OMIM:256040), Inflammatory (MESH:D007249), central nervous system complication (MESH:D002493), neuroinflammation (MESH:D000090862), schizophrenia (MESH:D012559), surgical (MESH:D007431), BBB damage (MESH:C536830), cancer (MESH:D009369), AD (MESH:D000544), memory decline (MESH:D060825), lung cancer (MESH:D008175), neurotoxic (MESH:D020258)
- **Chemicals:** ATP (MESH:D000255), ROS (MESH:D017382), tryptophan (MESH:D014364), tadalafil (MESH:D000068581), Sevoflurane (MESH:D000077149), sildenafil (MESH:D000068677), 20S CP (-), Dexmedetomidine (MESH:D020927), tamarixetin (MESH:C508967), Isoflurane (MESH:D007530), roflumilast (MESH:C424423), quinolinic acid (MESH:D017378), kynurenine (MESH:D007737), glutamate (MESH:D018698), propofol (MESH:D015742), Rolipram (MESH:D020889), cGMP (MESH:D006152)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935915/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935915/full.md

## References

121 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935915/full.md

---
Source: https://tomesphere.com/paper/PMC12935915